Madrigal Pharmaceuticals (MDGL) Debt Ratio (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) has 12 years of Debt Ratio data on file, last reported at 0.28 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.28, up 134.19% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.28 (up 134.19% YoY), and the FY2025 annual result was 0.27, up 139.21% from the prior year.
• Debt Ratio improved to 0.28 in Q1 2026 per MDGL's latest filing, from 0.27 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.48 in Q3 2023 and troughed at 0.11 in Q2 2024.
• A 5-year average of 0.21 and a median of 0.2 in 2022 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio plunged 77.37% in 2024, then soared 139.21% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.14 in 2022, then jumped by 32.62% to 0.18 in 2023, then sank by 37.43% to 0.11 in 2024, then surged by 139.21% to 0.27 in 2025, then increased by 2.76% to 0.28 in 2026.
• Business Quant data shows MDGL's Debt Ratio at 0.28 in Q1 2026, 0.27 in Q4 2025, and 0.25 in Q3 2025.